''It seems more than ever likely that blood-derived stem tive capacity. 47-49 In the allogeneic
setting, mobilized blood cells have also been used instead of BM. 50 Umbilical cord cells …

PURPOSE: To review recent advances in peripheral-blood progenitor-cell (PBPC)
transplantation in order to define the optimal cell dose required for autologous and …

The increased use of Peripheral Blood Stem Cells (PBSC) to reconstitute hematopoiesis in
autotransplant and, more recently, allotransplant settings has not been associated with a …

Background In this study we tried to achieve successful transplantation in patients with acute
leukemia with the use of hematopoietic stem cells from donors who shared only one HLA …

Rapid and accurate differentiation of cell types within a heterogeneous solution is a
challenging but important task for various applications in biological research and medicine …

PURPOSE To analyze factors that affect the collection of peripheral-blood stem cells (PBSC)
before transplant and the tempo of engraftment after transplant. PATIENTS AND METHODS …

In concert with the International Society of Hematotherapy and Graft Engineering (ISHAGE),
we previously described a set of guidelines for detection of CD34+ cells based on a four …

High-dose therapy is an effective standard treatment for multiple myeloma patients.
Evidence that intermediate-dose therapy improves survival is limited. At diagnosis, about …

Despite the need for alternative sources of human hematopoietic stem cells (HSCs), the
functional capacity of hematopoietic cells generated from human embryonic stem cells …

We report the results of two prospective phase II studies investigating the role of high-dose
sequential chemotherapy, followed by autologous stem cell transplantation (ASCT) in 62 …